Pharmafile Logo
Pharmafocus logo
Advanced Search
marie_innes_1

New director for Cello Health Insight

July 8, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cello, Kantar Health, marie innes

Healthcare market research agency Cello Health Insight has appointed Marie Innes as director. Based in the firm’s London head office …

Appointment

Rise in diabetes ‘alarming’

July 7, 2014
Sales and Marketing NHS, diabetes, nhs scotland, type 2

NHS Scotland has spent around £230 million on diabetes and obesity drugs in the past three years, according to data …

News
gsk image

Mekinist shown EU green light

July 7, 2014
Sales and Marketing CHMP, Cancer, GSK, Tafinlar, braf, mekinist, melanoma

The European Commission has given GlaxoSmithKline’s melanoma drug Mekinist the thumbs-up following a positive opinion in April from the European …

News
amy_schulman_alynlam

Alynlam secures fomer Pfizer head

July 7, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pfizer, alynlam, amy schulman

US biotech firm Alynlam has elected Pfizer’s former executive VP and general counsel Amy Schulman to its board of directors. …

Appointment
Roche image

Roche lung cancer drug sees first approval

July 4, 2014
Sales and Marketing ALK+, Cancer, NSCLC, Pfizer, Roche, Xalkori, alectinib, alk, zykadia

Roche has seen the first approval for its new lung cancer drug alectinib in Japan as it looks to compete …

News
FDA image

Spectrum wins FDA approval for rare cancer drug

July 4, 2014
Research and Development, Sales and Marketing Beleodaq, Cancer, FDA, Spectrum, non-Hodgkin lymphoma

In an expedited review the FDA has approved a new cancer drug from Spectrum Pharmaceuticals to treat a rare cancer …

News
st jude image

FDA clears St. Jude Medical

July 4, 2014
Manufacturing and Production, Sales and Marketing CardioMEMS, FDA, california, st jude medical

US medical device manufacturer St. Jude Medical has been given a clean bill of health by the Food and Drug …

News
NHS image

Unison warns of ‘dangerous’ £1 billion NHS tender

July 4, 2014
Sales and Marketing CCG, England, NHS, commissioning, unison

A row is bubbling over the provision of health services in Staffordshire after a trade union accused four NHS clinical …

News
ann-tove_kongsnes_

Pharmalink elects three to board

July 4, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ann-Tove Kongsnes, Hilde Furberg, Olav Hellebø, Pharmalink, ab

Swedish speciality pharma firm Pharmalink AB has appointed Ann-Tove Kongsnes, Hilde Furberg and Olav Hellebø to its board of directors. …

Appointment

Majority of consumed Viagra fake say researchers

July 3, 2014
Manufacturing and Production, Sales and Marketing BMJ, ED, Pfizer, Sildenafil, counterfeit, erectile dysfunction, viagra

At least two-thirds of Pfizer’s erectile dysfunction drug Viagra used in the Netherlands may be illegal, researchers are warning. In …

News
novartis image

Novartis faces data fraud charges in Japan

July 3, 2014
Medical Communications, Sales and Marketing Diovan, Japan, Novartis, data, fraud, heart, valsartan

Novartis is facing criminal charges in Japan over the alleged falsifying of data for its once big-selling heart drug Diovan. …

News

France ‘to approve’ Avastin use

July 3, 2014
Sales and Marketing AMD, France, Lucentis, Novartis, Roche, avastin, off label, off-label, wet AMD

The French government is planning to allow Roche’s cancer drug Avastin to be prescribed off-label to treat wet age-related macular …

News
Genentech image

Genentech to buy Seragon

July 3, 2014
Sales and Marketing Genentech, Roche, breast cancer, oncology, serds

Roche subsidiary Genentech is to pay around $1.7 billion for biotech firm Seragon Pharmaceuticals to secure its portfolio of potential …

News
annalisa_prosensa

Prosensa makes two key appointments



July 3, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Prosensa, Willem W. van Weperen. Annalisa Jenkins

Dutch biopharma firm Prosensa has appointed Willem W. van Weperen as chief commercial officer and Dr Annalisa Jenkins to its …

Appointment

World facing medical ‘dark ages’ over antibiotic resistance

July 2, 2014
Medical Communications, Research and Development, Sales and Marketing Antibiotics, BRIC, Cameron, MINT, UK, o'neill, oneill, resistance

The UK Government has pledged to become a world leader in tackling antibiotic resistance in the face of a medical …

News
Amgen image

FDA breakthrough for Amgen

July 2, 2014
Research and Development, Sales and Marketing Amgen, BiTE antibody blinatumomab, FDA, all, leukaemia

Amgen has taken a major step down the road to getting its investigational cancer drug blinatumomab onto the market after …

News
J&J image

J&J completes $4 billion OCD sale

July 2, 2014
Sales and Marketing J&J, JJ, Johnson and Johnson, Ortho-Clinical Diagnostics, carlyle, ocd

Johnson & Johnson has sold its Ortho-Clinical Diagnostics (OCD) business to private equity investor The Carlyle Group for ‘approximately $4 …

News

Fishawack buys Brighton comms agency

July 2, 2014
Medical Communications Brighton, Facilitate, comms, fishawack

Medical communications firm Fishawack has acquired the UK, Brighton-based agency Facilitate as part of its
 ongoing purchasing strategy. Facilitate will …

News
Merck image

PD-1 cancer race heats up as Merck takes lead

July 2, 2014
Research and Development, Sales and Marketing ASCO, Cancer, Merck, melanoma, mk3475, oncology, pembrolizumab

Merck’s oncology drug pembrolizumab has taken a big step towards becoming Europe’s first PD-1 cancer treatment as the EMA accepts …

News
james_smith_reuters_pfizer

Reuters chief executive joins Pfizer board

July 2, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pfizer, james smith, reuters

Pfizer has appointed the chief executive of information and media giant Thomson Reuters to its board of directors. James Smith …

Appointment
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026